Announcement of a Meeting to Explore Feasibility of Establishing a NIST/Industry Consortium on Gene Expression Metrology, 19931 [05-7592]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 72 / Friday, April 15, 2005 / Notices
the Department of its final
determination pursuant to section
735(b)(1)(A)(i) of the Act that an
industry in the United States is
materially injured by reason of lessthan-fair-value imports of magnesium
from Russia. Therefore, in accordance
with section 736(a)(1) of the Act, the
Department will direct U.S. Customs
and Border Protection (CBP) to assess,
upon further instruction by the
Department, antidumping duties equal
to the amount by which the normal
value of the merchandise exceeds the
export price (or the constructed export
price) of the merchandise for all
relevant entries of magnesium from
Russia. These antidumping duties will
be assessed on all entries of magnesium
from Russia entered, or withdrawn from
warehouse, for consumption on or after
October 4, 2004, the date on which the
Department published its notice of
preliminary determination in the
Federal Register. See Notice of
Preliminary Determination of Sales at
Less Than Fair Value and Postponement
of Final Determination: Magnesium
Metal From the Russian Federation, 69
FR 59197 (October 4, 2004) (Preliminary
Determination).
Section 733(d) of the Act states that
instructions issued pursuant to an
affirmative preliminary determination
may not remain in effect for more than
four months except where exporters
representing a significant proportion of
exports of the subject merchandise
request the Department to extend that
four-month period to no more than six
months. At the request of exporters that
account for a significant proportion of
the Russian exports of subject
merchandise, we extended the fourmonth period to no more than six
months. See Preliminary Determination.
In this investigation, the six-month
period beginning on the date of the
publication of the Preliminary
Determination ended on April 1, 2005.
Furthermore, section 737 of the Act
states that definitive duties are to begin
on the date of publication of the ITC’s
final injury determination. Therefore, in
accordance with section 733(d) of the
Act and our practice, we will instruct
CBP to terminate the suspension of
liquidation and to liquidate, without
regard to antidumping duties,
unliquidated entries of magnesium from
Russia entered, or withdrawn from
warehouse, for consumption on or after
April 2, 2005, and before the date of
publication of the ITC ’s final injury
determination in the Federal Register.
Suspension of liquidation will continue
on or after this date.
Effective on the date of publication of
the ITC’s final affirmative injury
VerDate jul<14>2003
14:34 Apr 14, 2005
Jkt 205001
determination, CBP officers must
require, at the same time as importers
would normally deposit estimated
duties on this merchandise, a cash
deposit equal to the estimated weightedaverage antidumping duty margins as
noted below. The all others’ rate applies
to all manufacturers and exporters of
subject merchandise not specifically
listed. The weighted-average dumping
margins are as follows:
Manufacturer/exporter
Margin
(percent)
JSC AVISMA Titanium-Magnesium Works ...........................
Solikamsk Magnesium Works ..
All Others’ .................................
21.71
18.65
21.01
Pursuant to section 736(a) of the Act,
this notice constitutes the antidumping
duty order with respect to magnesium
metal from Russia. Interested parties
may contact the Department’s Central
Records Unit, Room B–099 of the main
Commerce Building, for copies of an
updated list of antidumping duty orders
currently in effect.
This order is issued and published in
accordance with section 736(a) of the
Act and 19 CFR 351.211.
Dated: April 12, 2005.
Joseph A. Spetrini,
Acting Assistant Secretary for Import
Administration.
[FR Doc. E5–1791 Filed 4–14–05; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
National Institute of Standards and
Technology
Announcement of a Meeting to Explore
Feasibility of Establishing a NIST/
Industry Consortium on Gene
Expression Metrology
National Institute of Standards
and Technology, Commerce.
ACTION: Notice of public meeting.
AGENCY:
SUMMARY: The National Institute of
Standards and Technology (NIST)
invites interested parties to attend a preconsortium meeting on May 16, 2005 to
be held on the NIST campus in Boulder,
Colorado. The goal of the one-day
meeting is to evaluate industry interest
in creating a NIST/industry consortium
focused on gene expression metrology.
The goals of such a consortium would
include the development of
measurement methods of known quality
for microarray gene expression results.
The consortium would be supervised
and administered by NIST. Consortium
research and development would be
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
19931
conducted by NIST staff members along
with at least one technical
representative from each participating
member company. Membership in the
Consortium is open to manufacturers of
complete microarray gene expression
systems (i.e. systems which include all
components required to measure a
genome-wide expression profile form
isolated RNA). Consortium Members
will be required to provide the NIST
staff members with a complete system
representative of their technology
platform to support measurement and
standards development. The initial term
of the consortium is intended to be three
years.
DATES: The meeting will take place on
May 17, 2005, at 8 a.m. to 5 p.m.
Interested parties should contact NIST
to confirm their interest at the address,
telephone number or FAX number
shown below.
ADDRESSES: The meeting will take place
at the National Institute of Standards
and Technology (NIST), 325 Broadway
Room 4550, Boulder, Colorado.
FOR FURTHER INFORMATION CONTACT:
Marc Salit, Advanced Chemical Science
Laboratory, Stop 8310, National
Institute of Standards and Technology
(NIST), Gaithersburg, MD 20899–8310.
Telephone: (301) 975–3646; FAX: 301
975–5449; e-mail: salit@nist.gov.
SUPPLEMENTARY INFORMATION: Any
program undertaken will be within the
scope and confines of The Federal
Technology Transfer Act of 1986 (Pub.
L. 99–502, 15 U.S.C. 3710a), which
provides federal laboratories including
NIST, with the authority to enter into
cooperative research agreements with
qualified parties. Under this law, NIST
may contribute personnel, equipment,
and facilities but no funds to the
cooperative research program. This is
not a grant program.
Dated: April 8, 2005.
Hratch G. Semerjian,
Acting Director.
[FR Doc. 05–7592 Filed 4–14–05; 8:45 am]
BILLING CODE 3510–13–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Submission for OMB Review;
Comment Request
The United States Patent and
Trademark Office (USPTO) has
submitted to the Office of Management
and Budget (OMB) for clearance the
following proposal for collection of
information under the provisions of the
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 70, Number 72 (Friday, April 15, 2005)]
[Notices]
[Page 19931]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7592]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
National Institute of Standards and Technology
Announcement of a Meeting to Explore Feasibility of Establishing
a NIST/Industry Consortium on Gene Expression Metrology
AGENCY: National Institute of Standards and Technology, Commerce.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The National Institute of Standards and Technology (NIST)
invites interested parties to attend a pre-consortium meeting on May
16, 2005 to be held on the NIST campus in Boulder, Colorado. The goal
of the one-day meeting is to evaluate industry interest in creating a
NIST/industry consortium focused on gene expression metrology. The
goals of such a consortium would include the development of measurement
methods of known quality for microarray gene expression results. The
consortium would be supervised and administered by NIST. Consortium
research and development would be conducted by NIST staff members along
with at least one technical representative from each participating
member company. Membership in the Consortium is open to manufacturers
of complete microarray gene expression systems (i.e. systems which
include all components required to measure a genome-wide expression
profile form isolated RNA). Consortium Members will be required to
provide the NIST staff members with a complete system representative of
their technology platform to support measurement and standards
development. The initial term of the consortium is intended to be three
years.
DATES: The meeting will take place on May 17, 2005, at 8 a.m. to 5 p.m.
Interested parties should contact NIST to confirm their interest at the
address, telephone number or FAX number shown below.
ADDRESSES: The meeting will take place at the National Institute of
Standards and Technology (NIST), 325 Broadway Room 4550, Boulder,
Colorado.
FOR FURTHER INFORMATION CONTACT: Marc Salit, Advanced Chemical Science
Laboratory, Stop 8310, National Institute of Standards and Technology
(NIST), Gaithersburg, MD 20899-8310. Telephone: (301) 975-3646; FAX:
301 975-5449; e-mail: salit@nist.gov.
SUPPLEMENTARY INFORMATION: Any program undertaken will be within the
scope and confines of The Federal Technology Transfer Act of 1986 (Pub.
L. 99-502, 15 U.S.C. 3710a), which provides federal laboratories
including NIST, with the authority to enter into cooperative research
agreements with qualified parties. Under this law, NIST may contribute
personnel, equipment, and facilities but no funds to the cooperative
research program. This is not a grant program.
Dated: April 8, 2005.
Hratch G. Semerjian,
Acting Director.
[FR Doc. 05-7592 Filed 4-14-05; 8:45 am]
BILLING CODE 3510-13-P
